Sarepta Therapeutics, Inc. (LON:0L35)
38.38
+1.19 (3.19%)
At close: May 20, 2025
Sarepta Therapeutics Employees
Sarepta Therapeutics had 1,372 employees as of December 31, 2024. The number of employees increased by 58 or 4.41% compared to the previous year.
Employees
1,372
Change (1Y)
58
Growth (1Y)
4.41%
Revenue / Employee
1.26M GBP
Profits / Employee
-140.12K GBP
Market Cap
2.84B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
GSK plc | 68,629 |
Haleon | 24,561 |
Smith & Nephew | 17,349 |
ConvaTec Group | 10,489 |
Hikma Pharmaceuticals | 9,500 |
HUTCHMED (China) | 1,811 |
Genus | 3,500 |
Sarepta Therapeutics News
- 7 days ago - Sarepta Therapeutics Shares New Protein Expression and Safety Results from ENDEAVOR in Participants 2 Years Old at Time of Treatment - Business Wire
- 7 days ago - Sarepta Therapeutics Presents Data at the American Society of Gene & Cell Therapy Conference, Including Statistically Significant Functional Outcomes for 8- and 9-Year-Old Patients in New Data Analysis of EMBARK Part 2 - Business Wire
- 10 days ago - Sarepta Therapeutics Announces Approval in Japan of ELEVIDYS, a Gene Therapy to Treat Duchenne Muscular Dystrophy - Business Wire
- 13 days ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sarepta Therapeutics, Inc. - SRPT - Accesswire
- 13 days ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sarepta Therapeutics, Inc. - SRPT - GlobeNewsWire
- 14 days ago - Top 3 Health Care Stocks That Are Preparing To Pump This Quarter - Benzinga
- 14 days ago - Sarepta Therapeutics to Present at the BofA Securities Health Care Conference - Business Wire
- 14 days ago - SA analyst downgrades: BTI, HSY, SRPT, HIMS, S - Seeking Alpha